IP Library Granted Patent US 8,273,875
Granted Patent B2
US 8,273,875 · App. 12/619,536 · Granted Sep 25, 2012

High performance luminescent compounds

Assignees: University of Notre Dame du Lac; Molecular Targeting Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,273,875
App. No.
12/619,536
Granted
Sep 25, 2012
Kind
B2
Abstract

Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to novel near-infrared dyes that are photostable and resistant to quenching. The dyes belong to a novel family of squaraine rotaxanes, and they are particularly well-suited for use in biological applications. Also disclosed are methods of synthesizing the dyes and methods of using the dyes.

Claims (76)

1. A compound having the formula:

or a pharmaceutically acceptable salt thereof, wherein:

R 1 , R 2 , and R 3 are each independently alkyl, phenyl, polyethylene glycol, alkyl-phosphonate, alkyl-sulfonate, methylene-triazole-alkyl-sulfonate, methylene-triazole-alkyl-phosphonate, methylene-triazole-methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate;

X=alkyl, phenyl, alkyl-carboxylic acid, alkyl ester, alkyl hydroxysuccinimde ester, alkyl maleimide, alkyl isothiocyanate, alkyl azide, alky alkyne, alkyl haloacetamido, aryl ester, aryl hydroxysuccinimde ester, aryl maleimide, aryl isothiocyanate, aryl azide, aryl alkyne, or aryl haloacetamido;

Y 1 and Y 2 are each independently H, alkoxy-triazole-methylene-sulfonate, alkoxy-triazole-methylene-dimethylammonium-alkyl-sulfonate, alkoxy-triazole-methylene-phosphonate, alkoxy-triazole-methylene-dimethylammonium-alkyl-phosphonate, triazole-methylene-sulfonate, triazole-methylene-phosphonate; triazole-methylene-dimethylammonium-alkyl-sulfonate, triazole-methylene-methylene-dimethylammonium-alkyl-phosphonate, alkyl, phenyl, alkyl-carboxylic acid, alkyl ester, alkyl hydroxysuccinimde ester, alkyl maleimide, alkyl isothiocyanate, alkyl azide, alky alkyne, alkyl haloacetamido, aryl ester, aryl hydroxysuccinimde ester, aryl maleimide, aryl isothiocyanate, aryl azide, aryl alkyne, or aryl haloacetam;

Z 1 and Z 2 are each independently CH or N; and

W 1 , W 2 , W 3 , and W 4 are each independently H or OH, at least one of W 1 , W 2 , W 3 , and W 4 being OH.

2. The compound of claim 1 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate; and

Z═CH or N.

3. The compound of claim 2 , wherein the compound has the formula:

4. The compound of claim 1 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate; and

Z═CH or N.

5. The compound of claim 1 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein;

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate; and

Z═CH or N.

6. The compound of claim 1 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and r are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate; and

Z═CH or N.

7. The compound of claim 6 , wherein the compound has the formula:

8. The compound of claim 1 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate; and

Z═CH or N.

9. The compound of claim 1 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate; and

Z═CH or N.

10. A compound having the formula:

or a pharmaceutically acceptable salt thereof, wherein:

R 1 , R 2 , and R 3 are each independently alkyl, phenyl, polyethylene glycol, alkyl-phosphonate, alkyl-sulfonate, methylene-triazole-alkyl-sulfonate, methylene-triazole-alkyl-phosphonate, methylene-triazole-methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate;

X=alkyl, phenyl, alkyl-carboxylic acid, alkyl ester, alkyl hydroxysuccinimde ester, alkyl maleimide, alkyl isothiocyanate, alkyl azide, alky alkyne, alkyl haloacetamido, aryl ester, aryl hydroxysuccinimde ester, aryl maleimide, aryl isothiocyanate, aryl azide, aryl alkyne, or aryl haloacetamido;

Y 1 and Y 2 are each independently H, alkoxy-triazole-methylene-sulfonate, alkoxy-triazole-methylene-dimethylammonium-alkyl-sulfonate, alkoxy-triazole-methylene-phosphonate, alkoxy-triazole-methylene-dimethylammonium-alkyl-phosphonate, triazole-methylene-sulfonate, triazole-methylene-phosphonate; triazole-methylene-dimethylammonium-alkyl-sulfonate, triazole-methylene-methylene-dimethylammonium-alkyl-phosphonate, alkyl, phenyl, alkyl-carboxylic acid, alkyl ester, alkyl hydroxysuccinimde ester, alkyl maleimide, alkyl isothiocyanate, alkyl azide, alkyl alkyne, alkyl haloacetamido, aryl ester, aryl hydroxysuccinimde ester, aryl maleimide, aryl isothiocyanate, aryl azide, aryl alkyne, or aryl haloacetamido; and

W 1 , W 2 , W 3 , and W 4 are each independently H or OH, at least one of W 1 , W 2 , W 3 , and W 4 being OH.

11. The compound of claim 10 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin; and

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate.

12. The compound of claim 10 , wherein the compound has the formula:

13. The compound of claim 10 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin; and

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate.

14. The compound of claim 13 , wherein the compound has the formula:

15. The compound of claim 10 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin; and

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate.

16. The compound of claim 10 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin; and

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, alkyl-phosphonate, methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate.

17. The compound of claim 10 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin; and T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, or alkyl-phosphonate.

18. The compound of claim 10 , wherein the compound has the formula:

or a pharmaceutically acceptable salt thereof, wherein:

X═OH, alkoxy, aryloxy, oxy-succinimide, NH-alkyl-maleimide, or NH-polyethylene glycol-biotin;

T 1 , T 2 , T 3 , T 4 , and T 5 are each independently H or a 1,2,3-triazole ring that is substituted with a group R, wherein R=polyethylene glycol, alkyl-sulfonate, or alkyl-phosphonate.

19. A compound having the formula:

or a pharmaceutically acceptable salt thereof, wherein:

R 1 , R 2 , and R 3 are each independently alkyl, phenyl, polyethylene glycol, alkyl-phosphonate, alkyl-sulfonate, methylene-triazole-alkyl-sulfonate, or methylene-triazole-alkyl-phosphonate, methylene-triazole-methylene-dimethylammonium-alkyl-sulfonate, or methylene-dimethylammonium-alkyl-phosphonate;

X=alkyl, phenyl, alkyl-carboxylic acid, alkyl ester, alkyl hydroxysuccinimde ester, alkyl maleimide, alkyl isothiocyanate, alkyl azide, alky alkyne, alkyl haloacetamido, aryl ester, aryl hydroxysuccinimde ester, aryl maleimide, aryl isothiocyanate, aryl azide, aryl alkyne, or aryl haloacetamido;

Y 1 and Y 2 are each independently H, alkoxy-triazole-methylene-sulfonate, alkoxy-triazole-methylene-dimethylammonium-alkyl-sulfonate, alkoxy-triazole-methylene-phosphonate, alkoxy-triazole-methylene-dimethylammonium-alkyl-phosphonate, triazole-methylene-sulfonate, triazole-methylene-phosphonate; triazole-methylene-dimethylammonium-alkyl-sulfonate, triazole-methylene-methylene-dimethylammonium-alkyl-phosphoriate, alkyl, phenyl, alkyl-carboxylic acid, alkyl ester, alkyl hydroxysuccinimde ester, alkyl maleimide, alkyl isothiocyanate, alkyl azide, alky alkyne, alkyl haloacetamido, aryl ester, aryl hydroxysuccinimde ester, aryl maleimide, aryl isothiocyanate, aryl azide, aryl alkyne, or aryl haloacetamido; and

W 1 , W 2 , W 3 , and W 4 are each independently H or OH.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 11, 2011
From: UNIVERSITY OF NOTRE DAME
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026569/0032 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2010
From: SMITH, BRADLEY
To: UNIVERSITY OF NOTRE DAME DU LAC
Reel/Frame 023978/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2010
From: EASWARAN, ARUNKUMAR
To: MOLECULAR TARGETING TECHNOLOGIES, INC.
Reel/Frame 023979/0062 →
Continuity (1)
Related Publication 20110118459A1 · May 19, 2011